advertisement

---

Kim YC 4

Showing records 1 to 4 | Display all abstracts from Kim YC

98774 Central retinal thickness changes and risk of neovascular glaucoma after intravitreal bevacizumab injection in patients with central retinal vein occlusion
Lee YH
Scientific reports 2022; 12: 2051

---

98066 A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells
Kim YC; Hsueh HT
Drug delivery and translational research 2022; 12: 826-837

---

98774 Central retinal thickness changes and risk of neovascular glaucoma after intravitreal bevacizumab injection in patients with central retinal vein occlusion
Kim YC
Scientific reports 2022; 12: 2051

---

98066 A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells
Shin MD; Berlinicke CA; Han H; Anders NM; Hemingway A; Leo KT; Chou RT; Kwon H; Appell MB; Rai U; Kolodziejski P; Eberhart C; Pitha I; Zack DJ; Hanes J; Ensign LM
Drug delivery and translational research 2022; 12: 826-837

---